MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies
1The Department of Biochemistry and Molecular Biology, The Institute for Medical Research-Israel-Canada, Hadassah Medical School, The Hebrew University of Jerusalem, Ein-Kerem, 91120 Jerusalem, Israel.
Abstract:
The initial response of lymphoid malignancies to glucocorticoids (GCs) is a critical parameter predicting successful treatment. Although being known as a strong inducer of apoptosis in lymphoid cells for almost a century, the signaling pathways regulating the susceptibility of the cells to GCs are only partly revealed. There is still a need to develop clinical tests that can predict the outcome of GC therapy. In this paper, I discuss important parameters modulating the pro-apoptotic effects of GCs, with a specific emphasis on the microRNA world comprised of small players with big impacts. The journey through the multifaceted complexity of GC-induced apoptosis brings forth explanations for the differential treatment response and raises potential strategies for overcoming drug resistance.
Insights
Glucocorticoids (GCs) induce apoptosis in lymphoid malignancies, but resistance varies. Understanding microRNA roles in GC-induced apoptosis could improve treatment prediction and overcome resistance.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glucocorticoids (GCs) are crucial for treating lymphoid malignancies, with initial response predicting treatment success.
- GCs induce apoptosis in lymphoid cells, a mechanism known for decades but incompletely understood.
- Predictive biomarkers for GC therapy outcomes in lymphoid cancers are needed.
Purpose of the Study:
- To explore factors influencing glucocorticoid-induced apoptosis in lymphoid malignancies.
- To highlight the role of microRNAs in modulating GC sensitivity and resistance.
- To discuss strategies for improving GC therapy efficacy.
Main Methods:
- Literature review and discussion of signaling pathways involved in GC-induced apoptosis.
- Focus on the regulatory role of microRNAs in GC response.
- Analysis of factors contributing to differential treatment outcomes.
Main Results:
- GCs induce apoptosis, but susceptibility varies significantly among lymphoid malignancy patients.
- MicroRNAs play a critical role in regulating cellular response to GCs.
- Understanding these regulatory pathways can explain differential treatment responses.
Conclusions:
- MicroRNAs are key regulators of glucocorticoid-induced apoptosis in lymphoid malignancies.
- Targeting microRNA pathways may offer strategies to overcome GC resistance.
- Further research into GC signaling and microRNA interactions is essential for developing predictive clinical tests.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
MicroRNAs
MicroRNAs
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
The Extrinsic Apoptotic Pathway

